Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Livongo Health Inc (LVGO)

Livongo Health Inc (LVGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,379,935
  • Shares Outstanding, K 97,817
  • Annual Sales, $ 170,200 K
  • Annual Income, $ -55,270 K
  • 60-Month Beta N/A
  • Price/Sales 33.60
  • Price/Cash Flow N/A
  • Price/Book 11.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +91.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.51 +42.36%
on 05/04/20
63.55 -15.97%
on 05/14/20
+9.69 (+22.17%)
since 04/27/20
3-Month
18.76 +184.65%
on 03/16/20
63.55 -15.97%
on 05/14/20
+27.94 (+109.74%)
since 02/27/20

Most Recent Stories

More News
Is Livongo (LVGO) Stock a Solid Choice Right Now?

Livongo (LVGO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

LVGO : 53.40 (-2.91%)
5 Digital Health Stocks to Soar Amid Coronavirus Crisis

The coronavirus pandemic has helped digital health surge like never before. With virtual visits increasing on a daily basis, we have five stocks that are set to gain.

UNH : 303.77 (+3.01%)
HUM : 399.34 (+0.57%)
ANTM : 287.25 (+1.35%)
TDOC : 162.64 (-1.11%)
ONEM : 31.23 (-8.63%)
LVGO : 53.40 (-2.91%)
Why Livongo (LVGO) Could Be Positioned for a Surge

Livongo (LVGO) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

LVGO : 53.40 (-2.91%)
Has Livongo Health (LVGO) Outpaced Other Medical Stocks This Year?

Is (LVGO) Outperforming Other Medical Stocks This Year?

LVGO : 53.40 (-2.91%)
New Strong Buy Stocks for May 13th

New Strong Buy Stocks for May 13th

PBYI : 10.80 (-7.06%)
LVGO : 53.40 (-2.91%)
LOMA : 4.59 (-4.38%)
KRTX : 87.97 (+3.12%)
AT : 2.12 (+0.47%)
Livongo Health: 1Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Livongo Health Inc. (LVGO) on Wednesday reported a loss of $5.6 million in its first quarter.

LVGO : 53.40 (-2.91%)
Livongo Health (LVGO) to Post Q1 Earnings: What's in Store?

Livongo Health (LVGO) first-quarter performance to reflect growth in core Livongo for Diabetes solution.

HAE : 109.30 (+1.19%)
EXAS : 82.11 (+1.61%)
ACB : 15.30 (-1.99%)
LVGO : 53.40 (-2.91%)
Livongo Health (LVGO) Stock Sinks As Market Gains: What You Should Know

Livongo Health (LVGO) closed at $41.37 in the latest trading session, marking a -1.52% move from the prior day.

LVGO : 53.40 (-2.91%)
The Zacks Analyst Blog Highlights: Livongo Health, Karuna Therapeutics, Sprouts Farmers Market, PennyMac Financial Services and Strategic Education

The Zacks Analyst Blog Highlights: Livongo Health, Karuna Therapeutics, Sprouts Farmers Market, PennyMac Financial Services and Strategic Education

STRA : 176.22 (+3.06%)
PFSI : 34.80 (+5.74%)
SFM : 24.82 (+1.55%)
KRTX : 87.97 (+3.12%)
LVGO : 53.40 (-2.91%)
Zacks.com featured highlights include: ThermoGenesis, 21Vianet, Livongo Health, Cue Biopharma and Sharps Compliance

Zacks.com featured highlights include: ThermoGenesis, 21Vianet, Livongo Health, Cue Biopharma and Sharps Compliance

SMED : 7.13 (+3.03%)
VNET : 15.14 (-0.13%)
CUE : 27.16 (-6.22%)
LVGO : 53.40 (-2.91%)
THMO : 5.94 (-6.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade LVGO with:

Business Summary

Livongo Health Inc. is a consumer digital health company. It offers Enter Livongo platform, which leverages data science and technology, for people with chronic conditions. The Company's Livongo platform offers solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes...

See More

Key Turning Points

2nd Resistance Point 57.96
1st Resistance Point 55.68
Last Price 53.40
1st Support Level 49.63
2nd Support Level 45.86

See More

52-Week High 63.55
Last Price 53.40
Fibonacci 61.8% 45.05
Fibonacci 50% 39.33
Fibonacci 38.2% 33.62
52-Week Low 15.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar